GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Danaher Corp (MEX:DHR) » Definitions » EV-to-EBITDA

Danaher (MEX:DHR) EV-to-EBITDA : 29.16 (As of Dec. 14, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Danaher EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Danaher's enterprise value is MXN3,731,849 Mil. Danaher's EBITDA for the trailing twelve months (TTM) ended in Sep. 2024 was MXN127,969 Mil. Therefore, Danaher's EV-to-EBITDA for today is 29.16.

The historical rank and industry rank for Danaher's EV-to-EBITDA or its related term are showing as below:

MEX:DHR' s EV-to-EBITDA Range Over the Past 10 Years
Min: 9.22   Med: 20.93   Max: 30.83
Current: 25.7

During the past 13 years, the highest EV-to-EBITDA of Danaher was 30.83. The lowest was 9.22. And the median was 20.93.

MEX:DHR's EV-to-EBITDA is ranked worse than
75.65% of 115 companies
in the Medical Diagnostics & Research industry
Industry Median: 16.24 vs MEX:DHR: 25.70

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-12-14), Danaher's stock price is MXN4700.00. Danaher's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was MXN93.389. Therefore, Danaher's PE Ratio (TTM) for today is 50.33.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).


Danaher EV-to-EBITDA Historical Data

The historical data trend for Danaher's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Danaher EV-to-EBITDA Chart

Danaher Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 21.48 24.36 26.41 19.79 24.64

Danaher Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 23.93 24.64 26.88 26.88 30.04

Competitive Comparison of Danaher's EV-to-EBITDA

For the Diagnostics & Research subindustry, Danaher's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Danaher's EV-to-EBITDA Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Danaher's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Danaher's EV-to-EBITDA falls into.



Danaher EV-to-EBITDA Calculation

Danaher's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=3731848.651/127969.302
=29.16

Danaher's current Enterprise Value is MXN3,731,849 Mil.
Danaher's EBITDA for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN127,969 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Danaher  (MEX:DHR) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Danaher's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=4700.00/93.389
=50.33

Danaher's share price for today is MXN4700.00.
Danaher's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN93.389.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?


Danaher EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Danaher's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Danaher Business Description

Address
2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, USA, 20037-1701
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Then, through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in the life science and diagnostic industries after the late 2023 divestiture of its environmental and applied solutions group, Veralto.